128 related articles for article (PubMed ID: 11248661)
1. Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli.
Sun HB; Yokota H
Bone; 2001 Mar; 28(3):303-9. PubMed ID: 11248661
[TBL] [Abstract][Full Text] [Related]
2. Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells.
Sun HB; Nalim R; Yokota H
Connect Tissue Res; 2003; 44(1):42-9. PubMed ID: 12945803
[TBL] [Abstract][Full Text] [Related]
3. Altered mRNA level of matrix metalloproteinase-13 in MH7A synovial cells under mechanical loading and unloading.
Sun HB; Yokota H
Bone; 2001 Apr; 28(4):399-403. PubMed ID: 11336920
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells.
Sun HB; Yokota H
Matrix Biol; 2002 Apr; 21(3):263-70. PubMed ID: 12009332
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Onodera S; Kaneda K; Mizue Y; Koyama Y; Fujinaga M; Nishihira J
J Biol Chem; 2000 Jan; 275(1):444-50. PubMed ID: 10617637
[TBL] [Abstract][Full Text] [Related]
6. Mechanical stretch regulates the expression of matrix metalloproteinase in rheumatoid arthritis fibroblast-like synoviocytes.
Wang P; Yang L; You X; Singh GK; Zhang L; Yan Y; Sung KL
Connect Tissue Res; 2009; 50(2):98-109. PubMed ID: 19296301
[TBL] [Abstract][Full Text] [Related]
7. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
[TBL] [Abstract][Full Text] [Related]
8. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.
Honda S; Migita K; Hirai Y; Origuchi T; Yamasaki S; Kamachi M; Shibatomi K; Fukuda T; Kita M; Hida A; Ida H; Aoyagi T; Kawakami A; Kawabe Y; Oizumi K; Eguchi K
Clin Exp Immunol; 2001 Oct; 126(1):131-6. PubMed ID: 11678909
[TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
Ma C; Chegini N
Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair.
Soo C; Shaw WW; Zhang X; Longaker MT; Howard EW; Ting K
Plast Reconstr Surg; 2000 Feb; 105(2):638-47. PubMed ID: 10697171
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
13. Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro.
Asano K; Sakai M; Matsuda T; Tanaka H; Fujii K; Hisamitsu T
J Pharm Pharmacol; 2006 Mar; 58(3):359-66. PubMed ID: 16536903
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
15. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
16. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
McLennan SV; Martell SK; Yue DK
Diabetes; 2002 Aug; 51(8):2612-8. PubMed ID: 12145178
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
19. Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
Araki Y; Tsuzuki Wada T; Aizaki Y; Sato K; Yokota K; Fujimoto K; Kim YT; Oda H; Kurokawa R; Mimura T
Arthritis Rheumatol; 2016 May; 68(5):1111-23. PubMed ID: 26713842
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
